|
1
|
Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract.
|
J Mol Biol
|
2007
|
2.45
|
|
2
|
Increasing the affinity of a human IgG1 for the neonatal Fc receptor: biological consequences.
|
J Immunol
|
2002
|
2.00
|
|
3
|
Macrophage impairment underlies airway occlusion in primary respiratory syncytial virus bronchiolitis.
|
J Infect Dis
|
2008
|
1.13
|
|
4
|
Isolation and characterization of monoclonal antibodies which neutralize human metapneumovirus in vitro and in vivo.
|
J Virol
|
2006
|
1.09
|
|
5
|
Opposing roles of membrane and soluble forms of the receptor for advanced glycation end products in primary respiratory syncytial virus infection.
|
J Infect Dis
|
2012
|
0.81
|